Showing 388 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP science

Two different cases of PrEP failure despite high adherence underline that such events are rare, but should not be ignored

News
4 September 2020
PrEP

PrEP, sex, intimacy and mental health A research briefing

About HIV
September 2020
Mental & emotional health problems

Sexual compulsivity and harmful drug use decreased in men who started PrEP in Amsterdam

News
24 August 2020
Clinical trials

Designing a New Generation of HIV Prevention Efficacy Trials

Editor's pick
AVAC
23 August 2020
Transmission & prevention

Top 10 articles on HIV prevention from AIDS 2020

News
31 July 2020
Adherence

Novel Immunoassay Demonstrates Predictive Utility in PrEP Adherence, HIV Protection

Editor's pick
Infectious Disease Advisor
28 July 2020
PrEP science

An Advocates' Primer on Long-Acting Injectable Cabotegravir for PrEP

Editor's pick
AVAC
16 July 2020
Pharmaceutical industry

GSK's ViiV, touting superior long-acting data, can challenge Gilead in HIV prevention: analyst

Editor's pick
FiercePharma
13 July 2020
PrEP science

A second study finds introducing PrEP to Africa considerably reduces HIV infections in women

News
9 July 2020
PrEP policies & guidelines

On-demand PrEP is highly effective, but some may find it confusing

News
8 July 2020
Injectable & long-acting PrEP

Injectable PrEP offers superior efficacy to oral PrEP in clinical trial

News
7 July 2020
PrEP science

PrEP prevents an estimated three-quarters of HIV infections in people at risk in large African study

News
4 July 2020
Clinical trials

Malawian women keen to join HIV prevention trials during pregnancy

News
19 June 2020
PrEP science

The Dangers of Excluding Women From HIV Prevention Drug Tests

Editor's pick
WIRED
10 June 2020
PrEP science

Kaiser study shows no new HIV cases among PrEP 2-1-1 users

Editor's pick
Bay Area Reporter
9 June 2020
PrEP science

PrEP and drug resistance A research briefing

About HIV
June 2020
Adherence

OraSure to Buy UrSure, an HIV Startup That Tests Adherence to PrEP

Editor's pick
POZ
4 June 2020
PrEP policies & guidelines

Sex—and PrEP—During the Pandemic

Editor's pick
POZ
3 June 2020
PrEP science

Matthew Hodson talks about PrEP and STIs Video

May 2020
PrEP science

Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis (PrEP): Promising Results from HPTN 083

Editor's pick
TAG
21 May 2020
Injectable & long-acting PrEP

Seventy per cent fewer HIV infections seen with PrEP injections, compared with pills, in gay/bi men and trans women

News
18 May 2020
PrEP science

Long-acting injectable drug prevents HIV infections

Editor's pick
Science
18 May 2020
PrEP science

Global HIV prevention study to stop early after ViiV Healthcare’s long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP

Editor's pick
ViiV press release
18 May 2020
The search for an HIV prevention vaccine

HIV prevention trials paused during coronavirus crisis

News
22 April 2020